is a postdoctoral researcher at the Université de Lille within the PRISM laboratory – U1192 Inserm (Protéomique Réponse Inflammatoire Spectrométrie de Masse). Her research focuses on the development of next-generation CAR macrophages and the identification of novel target antigens for CAR therapy in triple-negative breast cancer (TNBC). She earned her PhD in Health Biology from the Université de Lille in 2024, where she developed Furin-inhibited CAR macrophages (CAR-M) to enhance their anti-tumor activity. She has contributed to several high-impact scientific publications and is one of the co-holders of a patent (PCT/FR2024/050238) related to Furin-inhibited CAR macrophages.
Early Career Symposium
| Time |
Session |
|
|
14:00
15:40
|
(Separate pre-registration required)
-
Welcome Message
-
FAK Inhibition Promotes Critical Cytotoxic Interactions Between CD8 T Cells and Cancer Cells in Metastatic Breast Cancer
-
Proffered Paper 1: Inhibition of Furin in CAR macrophages directs them toward a proinflammatory phenotype and enhances their antitumor activities
-
Proffered Paper 2: Multimodal analysis of spatial transcriptomics data uncovers novel invasive lobular carcinoma subtypes
-
Targeting cytokine signalling to block cancer-promoting inflammation and tumour progression
Auditorium VIII
|
